Unlock stock picks and a broker-level newsfeed that powers Wall Street.
Upgrade Now
NasdaqGS - Nasdaq Real Time Price USD

Exelixis, Inc. (EXEL)

Compare
36.39
-0.53
(-1.44%)
At close: April 1 at 4:00:02 PM EDT
36.79
+0.40
+(1.10%)
Pre-Market: 4:10:57 AM EDT

Research Analysis

Earnings Per Share

Consensus EPS
 

Revenue vs. Earnings

Revenue 566.75M
Earnings 139.86M

Q1'24

Q2'24

Q3'24

Q4'24

0
200M
400M
600M
 

Analyst Recommendations

  • Strong Buy
  • Buy
  • Hold
  • Underperform
  • Sell
 

Analyst Price Targets

23.00 Low
37.06 Average
36.39 Current
45.00 High

Earnings Estimate

Currency in USD Current Qtr. (Mar 2025)Next Qtr. (Jun 2025)Current Year (2025)Next Year (2026)
No. of Analysts 10101212
Avg. Estimate 0.410.562.32.85
Low Estimate 0.290.481.962.22
High Estimate 0.550.642.583.65
Year Ago EPS 0.170.8422.3

Revenue Estimate

Currency in USD Current Qtr. (Mar 2025)Next Qtr. (Jun 2025)Current Year (2025)Next Year (2026)
No. of Analysts 16162018
Avg. Estimate 497.89M551.24M2.25B2.49B
Low Estimate 433.7M494.4M2.14B2.16B
High Estimate 559.3M584.46M2.42B2.77B
Year Ago Sales 425.23M637.18M2.17B2.25B
Sales Growth (year/est) 17.09%-13.49%3.69%10.90%

Earnings History

Currency in USD 3/31/2024 6/30/2024 9/30/2024 12/31/2024
EPS Est. 0.290.370.420.49
EPS Actual 0.170.840.470.55
Difference -0.120.470.050.06
Surprise % -40.64%129.85%12.02%11.83%

EPS Trend

Currency in USD Current Qtr. (Mar 2025)Next Qtr. (Jun 2025)Current Year (2025)Next Year (2026)
Current Estimate 0.410.562.32.85
7 Days Ago 0.420.562.32.83
30 Days Ago 0.420.562.312.83
60 Days Ago 0.430.52.082.64
90 Days Ago 0.370.4922.53

EPS Revisions

Currency in USD Current Qtr. (Mar 2025)Next Qtr. (Jun 2025)Current Year (2025)Next Year (2026)
Up Last 7 Days 1112
Up Last 30 Days 1417
Down Last 7 Days --------
Down Last 30 Days --1--4

Growth Estimates

Current Qtr.Next Qtr.Current YearNext Year
EXEL 143.95%-33.43%14.90%24.14%
S&P 500 6.69%6.80%9.98%14.34%

Upgrades & Downgrades

Reiterates HC Wainwright & Co.: Buy to Buy 3/27/2025
Maintains RBC Capital: Outperform to Outperform 3/13/2025
Downgrade Wells Fargo: Overweight to Equal-Weight 2/24/2025
Maintains Barclays: Equal-Weight to Equal-Weight 2/13/2025
Reiterates HC Wainwright & Co.: Buy to Buy 2/13/2025
Reiterates HC Wainwright & Co.: Buy to Buy 2/13/2025

Related Tickers

INCY Incyte Corporation
60.91
+0.59%
 
HALO Halozyme Therapeutics, Inc.
61.87
-3.04%
 
ALNY Alnylam Pharmaceuticals, Inc.
255.76
-5.28%
 
ARGX argenx SE
567.09
-4.19%
 
ADMA ADMA Biologics, Inc.
19.42
-2.12%
 
CPRX Catalyst Pharmaceuticals, Inc.
23.92
-1.36%
 
JAZZ Jazz Pharmaceuticals plc
124.99
+0.68%
 
AXSM Axsome Therapeutics, Inc.
111.67
-4.25%
 
BBIO BridgeBio Pharma, Inc.
33.02
-4.48%
 
IONS Ionis Pharmaceuticals, Inc.
27.26
-9.65%